Next Article in Journal
Characterization and Cytotoxicity Studies of the Rare 21:4 n-7 Acid and Other Polyunsaturated Fatty Acids from the Marine Opisthobranch Scaphander lignarius, Isolated Using Bioassay Guided Fractionation
Previous Article in Journal
Adjuvant Activity of Sargassum pallidum Polysaccharides against Combined Newcastle Disease, Infectious Bronchitis and Avian Influenza Inactivated Vaccines
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2012, 10(12), 2661-2675;

Inhibition of Bladder Tumor Growth by Chitooligosaccharides in an Experimental Carcinogenesis Model

Institute for Molecular and Cellular Biology, Porto University, Porto 4150-180, Portugal
Institute of Pharmacology & Experimental Therapeutics, IBILI, Medicine Faculty, Coimbra University, Coimbra 3000-548, Portugal
CBQF/Biotechnology School, Portuguese Catholic University, Porto 4200-072, Portugal
Department of Urology & Renal Transplantation, Coimbra University Hospital, Coimbra 3000-075, Portugal
Service of Anatomic Pathology, Coimbra University Hospital, Coimbra 3000-075, Portugal
Department of Biochemistry, Pharmacy Faculty, Porto University, Porto 4050-313, Portugal
Author to whom correspondence should be addressed.
Received: 3 September 2012 / Revised: 8 October 2012 / Accepted: 8 November 2012 / Published: 26 November 2012
Full-Text   |   PDF [433 KB, uploaded 24 February 2015]   |  


Urinary bladder cancer is one of the most common cancers worldwide, with the highest incidence in industrialized countries. Patients with cancer commonly use unconventional and complementary therapy including nutraceuticals. In this study we evaluated the efficacy of chitooligosaccharides (in orange juice) in rat bladder cancer chemoprevention and as therapeutic agent, on a rat model of urinary bladder carcinogenesis induced with N-butyl-N-(4-hydroxybutyl) nitrosamine. Results indicate that chitooligosaccharides may have a preventive effect on bladder cancer development and a curative effect upon established bladder tumors, dependent on the concentration ingested 500 mg/kg b.w., every three days, showed capacity to inhibit and prevent the proliferation of bladder cancer; however, this was associated with secondary effects such as hypercholesterolemia and hypertriglyceridemia. The use of lower doses (50 and 250 mg/kg b.w.) showed only therapeutic effects. It is further suggested that this antitumor effect might be due to its expected anti-inflammatory action, as well as by mechanisms not directly dependent of COX-2 inhibition, such as cellular proliferation control and improvement in antioxidant profile. View Full-Text
Keywords: chitosans; bladder cancer; chemoprevention; chitooligosaccharides chitosans; bladder cancer; chemoprevention; chitooligosaccharides

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Fernandes, J.C.; Sereno, J.; Garrido, P.; Parada, B.; Cunha, M.F.X.; Reis, F.; Pintado, M.E.; Santos-Silva, A. Inhibition of Bladder Tumor Growth by Chitooligosaccharides in an Experimental Carcinogenesis Model. Mar. Drugs 2012, 10, 2661-2675.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top